We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.3%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGNA
1576
DELISTED
TEGNA Inc
TGNA
$50K ﹤0.01%
+3,284
New +$50.6K
ENZ
1577
DELISTED
Enzo Biochem, Inc.
ENZ
$50K ﹤0.01%
14,820
+12,570
+559% +$44.3K
DBD
1578
DELISTED
Diebold Nixdorf Incorporated
DBD
$50K ﹤0.01%
+5,480
New +$57.2K
PRSP
1579
DELISTED
Perspecta Inc. Common Stock
PRSP
$50K ﹤0.01%
2,139
-31,656
-94% -$711K
BEAT
1580
DELISTED
BioTelemetry, Inc.
BEAT
$50K ﹤0.01%
+1,030
New +$54.1K
BCE icon
1581
BCE
BCE
$21B
$49K ﹤0.01%
1,072
-2,037
-66% -$91.9K
HRI icon
1582
Herc Holdings
HRI
$5.68B
$49K ﹤0.01%
+1,060
New +$44.1K
MTZ icon
1583
MasTec
MTZ
$21.5B
$49K ﹤0.01%
945
-3,292
-78% -$163K
UNB icon
1584
Union Bankshares
UNB
$109M
$49K ﹤0.01%
+1,344
New +$50.5K
VRSN icon
1585
VeriSign
VRSN
$26.5B
$49K ﹤0.01%
232
-4,852
-95% -$953K
ALIM
1586
DELISTED
Alimera Sciences
ALIM
$49K ﹤0.01%
3,657
+3,646
+33,145% +$51.3K
TCF
1587
DELISTED
TCF Financial Corporation Common Stock
TCF
$49K ﹤0.01%
+1,192
New +$49.5K
AES icon
1588
AES
AES
$10.5B
$48K ﹤0.01%
2,896
-35,925
-93% -$609K
CHH icon
1589
Choice Hotels
CHH
$4.62B
$48K ﹤0.01%
547
-1,576
-74% -$131K
CTS icon
1590
CTS Corp
CTS
$1.85B
$48K ﹤0.01%
1,743
-3,990
-70% -$115K
ITOT icon
1591
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$48K ﹤0.01%
+718
New +$47K
KLAC icon
1592
KLA
KLAC
$252B
$48K ﹤0.01%
4,060
-39,700
-91% -$459K
MBI icon
1593
MBIA
MBI
$256M
$48K ﹤0.01%
5,162
-1,499
-23% -$14K
MSGS icon
1594
Madison Square Garden
MSGS
$9.43B
$48K ﹤0.01%
240
-1,051
-81% -$224K
NHTC icon
1595
Natural Health Trends
NHTC
$15M
$48K ﹤0.01%
5,895
+5,867
+20,954% +$61.3K
ON icon
1596
ON Semiconductor
ON
$31.1B
$48K ﹤0.01%
2,375
-18,263
-88% -$377K
SWKS icon
1597
Skyworks Solutions
SWKS
$10.4B
$48K ﹤0.01%
618
-3,607
-85% -$286K
TMV icon
1598
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$195M
$48K ﹤0.01%
1,410
+645
+84% +$25.4K
TRN icon
1599
Trinity Industries
TRN
$2.3B
$48K ﹤0.01%
2,345
-755
-24% -$16.1K
UFPI icon
1600
UFP Industries
UFPI
$5.01B
$48K ﹤0.01%
1,271
+1,105
+666% +$38.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.